Company News
Jeffrey Chodakewitz to join Vertex as Chief Medical Officer
Jeffrey Chodakewitz to join Vertex as Chief Medical Officer
Will also be Senior Vice President of Global Medicines Development
Actavis appoints new managers for its US Specialty Brands business
Actavis appoints new managers for its US Specialty Brands business
Four divisions will be women’s health, urology/gastroenterology, dermatology/established brands and business operations
Galderma announces CEO for North American Operations
Galderma announces CEO for North American Operations
Stuart Raetzman will join the dermatology firm on 1 March
Priaxon appoints Dr Constance Hoefer as Chief Development Officer
Priaxon appoints Dr Constance Hoefer as Chief Development Officer
Brings the necessary experience and knowledge for the Company to successfully advance Priaxon AG’s non-clinical programs towards the clinic
Tim Tasker joins Heptares as Chief Medical Officer
Tim Tasker joins Heptares as Chief Medical Officer
Increases focus on clinical development of GPCR-targeted drug candidates
Thomas Broeer elected as new BGMA Chairman
Thomas Broeer elected as new BGMA Chairman
Brings more than 20 years of industry experience to the position
KaloBios hires Harry Lam as Head of Manufacturing
KaloBios hires Harry Lam as Head of Manufacturing
He joins the firm with more than 28 years of biopharmaceutical manufacturing experience
Chris Kilbee appointed Group Director of UBM Pharma Portfolio
Chris Kilbee appointed Group Director of UBM Pharma Portfolio
Aims to expand the portfolio globally, putting increased emphasis on digital and content
SCM Pharma appoints US business development manager
SCM Pharma appoints US business development manager
Derek Richards takes up the role
Merck Serono appoints Steven Hildemann as Global Chief Medical Officer
Merck Serono appoints Steven Hildemann as Global Chief Medical Officer
He brings more than 20 years of experience to Merck Serono, across academic medicine and the pharmaceutical industry
TiGenix appoints Gri-Cel CEO and COO to Board of Directors
TiGenix appoints Gri-Cel CEO and COO to Board of Directors
Following strategic investment of EUR12m by Grifols
Sitka Biopharma appoints Sean Cunliffe as Chief Executive
Sitka Biopharma appoints Sean Cunliffe as Chief Executive
Canadian biotechnology firm is developing a treatment for bladder cancer
Richard Sachse takes Chief Scientific Officer role at Aeterna Zentaris
Richard Sachse takes Chief Scientific Officer role at Aeterna Zentaris
Takes responsibility for all global research and development activities at the Canadian firm
John van der Valk appointed MD of UBM Live Amsterdam
John van der Valk appointed MD of UBM Live Amsterdam
Takes responsibility for overseeing the company’s CPhI brand
Kemal Malik joins Bayer Board of Management and takes responsibility for Innovation
Kemal Malik joins Bayer Board of Management and takes responsibility for Innovation
Professor Wolfgang Plischke will retire on 30 April
Nuevolution appoints Ton Berkien as Chief Business Officer
Nuevolution appoints Ton Berkien as Chief Business Officer
He will lead the commercial and business development efforts of the Copenhagen-based firm
Celerion appoints John Horkulak as Executive Director, Eurasian Site Operations
Celerion appoints John Horkulak as Executive Director, Eurasian Site Operations
Will help expand early phase patient capabilities in Europe and Asia
Lorus Therapeutics completes new executive management team
Lorus Therapeutics completes new executive management team
Avanish Vellanki and Gregory Chow join Canadian biopharmaceutical company as Chief Business Officer and Chief Financial Officer
Aptuit names Jonathan Goldman as Chief Executive
Aptuit names Jonathan Goldman as Chief Executive
He joins the firm from global contract research organisation ICON Clinical Research
Hiroharu Okochi named new President of Harlan Japan
Hiroharu Okochi named new President of Harlan Japan
Harlan says there is growth potential in Asia-Pacific region
Glenmark appoints Philip Andrew Gioia as President North America and Global API Business
Glenmark appoints Philip Andrew Gioia as President North America and Global API Business
He joins the Indian pharmaceutical firm from Bausch & Lomb
Novasep promotes Nadege Laborde to President of Industrial Biotech Business Unit
Novasep promotes Nadege Laborde to President of Industrial Biotech Business Unit
Laborde has been with Novasep since 2000
Theravectys makes two appointments to strengthen executive committee
Theravectys makes two appointments to strengthen executive committee
Hires a Head of Clinical Development and a Head of Strategy and Business Development
Harlan Korea names new President
Harlan Korea names new President
Kwan Goo Edmond (Ed) Cho takes responsibility for Harlan Contract Research Services\' business in Korea